跳至主要内容
临床试验/NCT02374593
NCT02374593已完成不适用

Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism

Erica Eugster1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
Dose Adjustments

研究概览

简要总结

This is a clinical study comparing targeted levothyroxine dosing based on thyroid anatomy as visualized on ultrasound (normal vs. ectopic/sublingual vs. athyreosis) to empiric levothyroxine dosing in infants with congenital hypothyroidism. Patients enrolled in the study for targeted dosing will be compared to controls obtained by retrospective chart review. The main outcome is to determine if there is a difference in the frequency of over-treatment and under-treatment during the first 6 months of therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 2 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Newborns diagnosed with congenital hypothyroidism (CH).
  • Newborns with CH who are treated by a pediatric endocrinologist at Riley Hospital for Children or satellite location.
  • Newborns with CH who have thyroid imaging performed (thyroid ultrasound or technetium scan) at diagnosis.

排除标准

  • Newborns who do not have CH.
  • Newborns with CH who have not had thyroid imaging performed at diagnosis.

研究组 & 干预措施

Targeted dosing

Experimental

Patients in this arm will receive targeted levothyroxine dosing based on thyroid anatomy on ultrasound as follows: 10 mcg/kg for normal gland, 12 mcg/kg for ectopic gland, 15 mcg/kg for athyreosis.

干预措施: Levothyroxine (Drug)

Targeted dosing

Experimental

Patients in this arm will receive targeted levothyroxine dosing based on thyroid anatomy on ultrasound as follows: 10 mcg/kg for normal gland, 12 mcg/kg for ectopic gland, 15 mcg/kg for athyreosis.

干预措施: Ultrasound (Device)

结局指标

主要结局

Dose Adjustments

时间窗: 6 months

Thyroid labs (TSH and fT4/T4) will be monitored per standard care: 2 weeks after initiation of levothyroxine and once monthly during the first 6 months of treatment. The number of dose adjustments required per participant during the first 6 months of treatment were recorded.

次要结局

  • Number of Adjustments Due to Overtreatment in Subjects With Athyreosis, Ectopic and Eutopic Thyroid Glands Compared With Controls(6 months)

研究者

发起方
Erica Eugster
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Erica Eugster

Pediatric Endocrinologist

Indiana University

研究点 (1)

Loading locations...

相似试验